Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England.
Gema RequenaAlexandrosz CziraVictoria L BanksRobert P WoodTheo TrittonCatherine M CastilloJie YeapRosie A C WildChris ComptonKieran J RothnieFelix J F HerthJennifer Kathleen QuintAfisi S IsmailaPublished in: International journal of chronic obstructive pulmonary disease (2023)
UMEC/VI demonstrated non-inferiority to IND/GLY in moderate-to-severe exacerbation reduction at 6, 12 and 18 months. These results support previous findings demonstrating similarity between UMEC/VI and IND/GLY on reduction of moderate-to-severe exacerbations.